Product Information
TELMISARTAN 40 MG TABLET is a generic product labeled by Lifestar Pharma LLC, priced at $0.1536 per EA under NDC 70756031330. Its NADAC has been published 74 times since Mar 26, 2025.
FDA first approved this application on Oct 15, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Lifestar Pharma LLCNDC
70756031330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA218157FDA Approved
10/15/2024
TE Code
AB
On Market Since
10/15/2024
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 40 MG TABLET has been published 74 times since Mar 26, 2025, and over the history we have for it it has declined 28.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1536 per EA |
|---|---|
| All-time high | $0.2186 (May 14, 2025) |
| All-time low | $0.1519 (Jul 22, 2026) |
| 52-week high | $0.1808 |
| 52-week low | $0.1519 |
| Median price | $0.1781 |
| Average price | $0.1804 |
| Largest weekly change | -13.8% (Jun 18, 2025) |
| Weeks tracked | 74 |
| Tracking since | Mar 26, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TELMISARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 40 MG TABLET, manufactured by Lifestar Pharma LLC, is $0.1536 per EA (NDC 70756031330), effective Aug 19, 2026.
How has the price of TELMISARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 40 MG TABLET has declined 28.1%. It has been tracked across 74 weekly CMS publications since Mar 26, 2025.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 40 MG TABLET?
Since Mar 26, 2025, the NADAC for TELMISARTAN 40 MG TABLET has ranged from a low of $0.1519 (Jul 22, 2026) to a high of $0.2186 (May 14, 2025), with a median of $0.1781 per EA.
Are there cheaper alternatives to TELMISARTAN 40 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TELMISARTAN 40 MG TABLET?
TELMISARTAN 40 MG TABLET (NDC 70756031330) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.